Tesla Bull Says There Are ‘No Winners’ With Trump’s Auto Tariffs, Calls It ‘Pure Chaos’ For Global Supply Chains

Government

Markets

Analyst Ratings

BIGC

LSPD

SHOP

While most discussions on trade and tariffs center around manufacturing and merchandise, software and service providers can be just as vulnerable. According to analysts, e-commerce software vendors and platforms such as Shopify Inc (NASDAQ: SHOP), Bigcommerce Holdings Inc (NASDAQ: BIGC), and Lightspeed Commerce Inc (TSE: LSPD) are the &#39;most exposed.&#39;

Trump Ends De Minimis Exemptions: Shopify, BigCommerce And Lightspeed Face New Headwinds

analyst ratings image

Analyst Expectations For Kroger&#39;s Future

Concept,Of,Economy,In,Mexico,,Good,Condition,,Weight,Improvement.

Analyst Color

Large Cap

Latin America

Regulations

Broad U.S. Equity ETFs

Emerging Markets

Emerging Market ETFs

Econ #s

ETFs

BOMXF

GPOVF

GPOVY

OPMXF

Mexican stocks rally despite Trump&#39;s tariff announcement. A surprising move to spare Mexico and Canada from tariffs.

Mexican Stocks Notch Widest 1-Day Rally Versus S&amp;P 500 Since 1998 As Trump Spares Mexico From Tariffs

Breaking Down Marex Group: 5 Analysts Share Their Views

Explore Soleno Therapeutics analyst ratings and price targets (NASDAQ:SLNO) on Benzinga. Stay updated on expert opinions and forecasts for SLNO stock.

Soleno Therapeutics Analyst Ratings and Price Targets | NASDAQ:SLNO | Benzinga

SOLENO THERAPEUTICS INC

Soleno Therapeutics

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

What Happened

News

Price Target

Trading Ideas

BILL

CRWD

PLNT

SAIA

SLNO

STLD

TSLA

TTGT

Tesla To $455? Here Are 10 Top Analyst Forecasts For Monday

Soleno Therapeutics (SLNO)

Movers

Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares are trading higher Thursday after the company announced it secured FDA approval for its first commercial drug, Vykat XR (diazoxide choline) extended-release tablets. 

Soleno Shares Are Up Today: What&#39;s Going On?

Macro,View,Of,Stacks,Of,Gold,Bars

Earnings

Equities

Eurozone

Commodities

Intraday Update

AUUD

DRMA

GTEC

Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results

Soleno Therapeutics Inc

Management

Press Releases

Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.

Soleno Therapeutics to Participate in Upcoming November Investor Conferences

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Health Care

Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

Financing

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

Soleno Therapeutics to Participate in Upcoming February Investor Conferences

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome

ACADIA Pharmaceuticals Inc. - Common Stock

ACADIA Pharmaceuticals

Arcellx

ADMA Biologics

Akero Therapeutics

Alvotech

Apellis Pharmaceuticals, Inc. - Common Stock

Apellis Pharmaceuticals

Biohaven

Catalyst Pharmaceuticals, Inc. - Common Stock

Catalyst Pharmaceuticals

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals

Cytokinetics, Incorporated - Common Stock

Cytokinetics

Amicus Therapeutics

Immunovant

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

Metsera

Vaxcyte

PTC Therapeutics

Protagonist Therapeutics, Inc. - Common Stock

Protagonist Therapeutics

Ultragenyx Pharmaceutical Inc. - Common Stock

Ultragenyx Pharmaceutical

Avidity Biosciences

Rhythm Pharmaceuticals, Inc. - Common Stock

Rhythm Pharmaceuticals

Scholar Rock Holding Corporation - Common Stock

Scholar Rock Holding

SpringWorks Therapeutics, Inc. - common stock

SpringWorks Therapeutics

Viking Therapeutics

Zai Lab Limited - American Depositary Shares

Zai Lab

HC Wainwright & Co.

Stifel

Guggenheim

Laidlaw & Co.

Baird

Application error: a client-side exception has occurred (see the browser console for more information).